UNRESECTABLE MELANOMA
Clinical trials for UNRESECTABLE MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot tested to boost cancer Drug's power against deadly skin cancer
Disease control TerminatedThis study tested if adding a new drug called CMP-001, injected directly into a tumor, could improve the effectiveness of the standard immunotherapy nivolumab for people with advanced melanoma that cannot be removed by surgery. It compared the combination treatment to nivolumab a…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE2, PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Doctors test engineered virus to attack deadly skin cancer
Disease control TerminatedThis early-phase study tested a genetically modified virus designed to kill melanoma cancer cells. The virus was injected directly into tumors and given intravenously to patients with advanced melanoma that had stopped responding to standard treatments. The main goals were to fin…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Can a malaria drug help beat tough skin cancer?
Disease control TerminatedThis study tested whether adding the drug hydroxychloroquine to a standard two-drug treatment (dabrafenib and trametinib) could better control advanced melanoma that has a specific BRAF gene mutation. It aimed to see if the three-drug combo could delay cancer growth longer than t…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New combo aims to reboot immune system against tough melanoma
Disease control TerminatedThis study tested a combination of two drugs, duvelisib (a pill) and nivolumab (an IV infusion), for people with advanced melanoma that could not be removed by surgery and had gotten worse despite standard immunotherapy. The goal was to see if adding duvelisib could help the immu…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC